Rosella Tomanin

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Mass Spectrometry

Replacement Therapy

Blood Brain Barrier

Hyaluronic Acid

Top Venues

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Journal of molecular medicine (Berlin, Germany)

This page only lists publications with an associated author ORCID identifier.

Publications

Alessandra Zanetti, Rosella Tomanin
Targeting Neurological Aspects of Mucopolysaccharidosis Type II: Enzyme Replacement Therapy and Beyond. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38 (5) (2024)
Alessandra Zanetti, Rosella Tomanin
Targeting Neurological Aspects of Mucopolysaccharidosis Type II: Enzyme Replacement Therapy and Beyond. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2024)
Alessandra Zanetti, Rosella Tomanin
Targeting Neurological Aspects of Mucopolysaccharidosis Type II: Enzyme Replacement Therapy and Beyond. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38 (5) (2024)
Alessandra Zanetti, Rosella Tomanin
Targeting Neurological Aspects of Mucopolysaccharidosis Type II: Enzyme Replacement Therapy and Beyond. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38 (5) (2024)
Francesca D'Avanzo, Alessandra Zanetti, Andrea Elena Dardis, Maurizio Scarpa, Nicola Volpi, Francesco Gatto, Rosella Tomanin
Mucopolysaccharidoses Differential Diagnosis by Mass Spectrometry-Based Analysis of Urine Free Glycosaminoglycans-A Diagnostic Prediction Model. Biomolecules 13 (3) (2023)
Francesca D'Avanzo, Alessandra Zanetti, Andrea Elena Dardis, Maurizio Scarpa, Nicola Volpi, Francesco Gatto, Rosella Tomanin
Mucopolysaccharidoses Differential Diagnosis by Mass Spectrometry-Based Analysis of Urine Free Glycosaminoglycans-A Diagnostic Prediction Model. Biomolecules 13 (3) (2023)
Francesca D'Avanzo, Alessandra Zanetti, Andrea Elena Dardis, Maurizio Scarpa, Nicola Volpi, Francesco Gatto, Rosella Tomanin
Mucopolysaccharidoses Differential Diagnosis by Mass Spectrometry-Based Analysis of Urine Free Glycosaminoglycans-A Diagnostic Prediction Model. Biomolecules 13 (3) (2023)
Francesca Maccari, Laura Rigon, Veronica Mantovani, Fabio Galeotti, Marika Salvalaio, Francesca D'Avanzo, Alessandra Zanetti, Federica Capitani, Orazio Gabrielli, Rosella Tomanin, Nicola Volpi
Glycosaminoglycan signatures in body fluids of mucopolysaccharidosis type II mouse model under long-term enzyme replacement therapy. Journal of molecular medicine (Berlin, Germany) 100 (8) (2022)
Francesca D'Avanzo, Alessandra Zanetti, Concetta De Filippis, Rosella Tomanin
Mucopolysaccharidosis Type VI, an Updated Overview of the Disease. International journal of molecular sciences 22 (24) (2021)
Alessandra Zanetti, Francesca D'Avanzo, Moeenaldeen AlSayed, Ana Carolina Brusius Facchin, Yin-Hsiu Chien, Roberto Giugliani, Emanuela Izzo, David C Kasper, Hsiang-Yu Lin, Shuan-Pei Lin, Laura Pollard, Akashdeep Singh, Rodolfo Tonin, Tim Wood, Amelia Morrone, Rosella Tomanin
Molecular basis of mucopolysaccharidosis IVA (Morquio A syndrome): A review and classification of GALNS gene variants and reporting of 68 novel variants. Human mutation 42 (11) (2021)
Concetta De Filippis, Barbara Napoli, Laura Rigon, Giulia Guarato, Reinhard Bauer, Rosella Tomanin, Genny Orso
Drosophila D-idua Reduction Mimics Mucopolysaccharidosis Type I Disease-Related Phenotypes. Cells 11 (1) (2021)
Rosella Tomanin, Litsa Karageorgos, Alessandra Zanetti, Moeenaldeen Al-Sayed, Mitch Bailey, Nicole Miller, Hitoshi Sakuraba, John J Hopwood
Mucopolysaccharidosis type VI (MPS VI) and molecular analysis: Review and classification of published variants in the ARSB gene. Human mutation 39 (12) (2018)